Key Takeaways
- Cathie Wood’s ARK Invest acquired $18.4 million worth of Coinbase stock spread across three exchange-traded funds
- The investment firm divested nearly $29 million in Robinhood shares, despite the stock remaining ARKK’s fourth-biggest position
- ARK disposed of $33 million worth of Roku stock while adding $46 million to its Eli Lilly holdings
- Robinhood shares surged 8.78% while Coinbase declined 2.57% on the trading day
- The Coinbase purchases followed the company’s launch of tokenized equity trading and AI advisory features
Cathie Wood’s investment management firm ARK Invest executed multiple significant portfolio adjustments on June 17, acquiring substantial stakes in Coinbase and Eli Lilly while reducing exposure to Robinhood and Roku.
The firm accumulated 111,799 Coinbase shares distributed among its ARKK, ARKW, and ARKF exchange-traded funds, representing approximately $18.4 million in value. The cryptocurrency exchange’s stock ended Wednesday’s session at $164.92, reflecting a 2.57% decline. Over the trailing 30-day period, Coinbase shares have retreated nearly 13%.
Additionally, ARK’s ARKK fund added 236,759 shares of Block Inc., valued at approximately $17.2 million. Block’s stock similarly retreated during the session, falling 2.46% to settle at $72.84.
Strategic Reduction in Robinhood and Roku Holdings
On the divestment front, ARK disposed of 275,572 Robinhood shares via its ARKK fund, generating roughly $26.7 million in proceeds. This marks a continuation of the previous week’s selling activity, when the firm unloaded 167,741 Robinhood shares on Thursday, signaling a deliberate trimming of this investment.
Despite ARK’s selling pressure, Robinhood stock posted impressive gains, climbing 8.78% to close at $105.20. The trading platform maintains its status as ARKK’s fourth-largest allocation at 4.87%, representing a position valued at $339.6 million.
ARK simultaneously reduced its Roku exposure by selling 239,267 shares across its ARKK, ARKW, and ARKF portfolios, generating approximately $33 million. This transaction followed more substantial Roku liquidations earlier in the week, including a 665,136-share sale on Monday.
Pharmaceutical Giant Receives Significant Investment
The day’s most substantial acquisition involved pharmaceutical powerhouse Eli Lilly. ARK purchased 41,138 shares through its ARKK and ARKG funds, deploying about $46.2 million. Eli Lilly shares declined modestly by 0.94%, closing at $1,112.
Following these transactions, Coinbase now represents ARKK’s eighth-largest holding, accounting for 3.71% of fund assets at $258.6 million.
The timing of ARK’s Coinbase accumulation coincided with major platform developments announced just one day earlier. On Tuesday, Coinbase unveiled plans enabling users to purchase, trade, and custody tokenized representations of U.S. equities. The company simultaneously rolled out a comprehensive platform upgrade incorporating AI-driven advisory capabilities and consolidated global liquidity spanning both spot cryptocurrency and derivatives markets.
Benchmark Equity Research maintained its Buy recommendation on Coinbase following these announcements, noting that the new offerings demonstrate the company’s evolution beyond pure cryptocurrency trading toward comprehensive financial infrastructure.
Robinhood made headlines Tuesday as well, revealing plans to eliminate 10% of its permanent workforce. Management characterized the restructuring as part of an initiative to establish a more streamlined operational framework.
Bernstein analysts highlighted earlier this week that Robinhood stands to capitalize on increased prediction market engagement connected to the World Cup, with daily trading volume escalating from $2.2 billion on June 11 to $4.8 billion by June 12.
ARK executed additional smaller transactions, including purchases of Alamar Biosciences and Generate Biomedicines shares, while reducing holdings in Strata Critical Medical and Twist Bioscience.
